Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEGF Trap in previously treated metastatic colorectal cancer
NCT00407654Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2006
- Primary completion
- Sep 2012
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of aflibercept in metastatic colorectal cancer (mCRC), sponsored by National Cancer Institute. Started Oct 2006; status: completed.
02
Drugs
aflibercept
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00407654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407654.